Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Metabolomics Biomarker Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Protein Marker
1.2.3 Nucleic Acid Marker
1.3 Market by Application
1.3.1 Global Metabolomics Biomarker Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Toxicological studies
1.3.3 Drug testing
1.3.4 Cancer
1.3.5 Cardiovascular disorders
1.3.6 Neurological disorders
1.3.7 Inborn errors of metabolism
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Metabolomics Biomarker Market Perspective (2018-2033)
2.2 Metabolomics Biomarker Growth Trends by Region
2.2.1 Global Metabolomics Biomarker Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Metabolomics Biomarker Historic Market Size by Region (2018-2023)
2.2.3 Metabolomics Biomarker Forecasted Market Size by Region (2024-2033)
2.3 Metabolomics Biomarker Market Dynamics
2.3.1 Metabolomics Biomarker Industry Trends
2.3.2 Metabolomics Biomarker Market Drivers
2.3.3 Metabolomics Biomarker Market Challenges
2.3.4 Metabolomics Biomarker Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Metabolomics Biomarker Players by Revenue
3.1.1 Global Top Metabolomics Biomarker Players by Revenue (2018-2023)
3.1.2 Global Metabolomics Biomarker Revenue Market Share by Players (2018-2023)
3.2 Global Metabolomics Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Metabolomics Biomarker Revenue
3.4 Global Metabolomics Biomarker Market Concentration Ratio
3.4.1 Global Metabolomics Biomarker Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Metabolomics Biomarker Revenue in 2022
3.5 Metabolomics Biomarker Key Players Head office and Area Served
3.6 Key Players Metabolomics Biomarker Product Solution and Service
3.7 Date of Enter into Metabolomics Biomarker Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Metabolomics Biomarker Breakdown Data by Type
4.1 Global Metabolomics Biomarker Historic Market Size by Type (2018-2023)
4.2 Global Metabolomics Biomarker Forecasted Market Size by Type (2024-2033)
5 Metabolomics Biomarker Breakdown Data by Application
5.1 Global Metabolomics Biomarker Historic Market Size by Application (2018-2023)
5.2 Global Metabolomics Biomarker Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Metabolomics Biomarker Market Size (2018-2033)
6.2 North America Metabolomics Biomarker Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Metabolomics Biomarker Market Size by Country (2018-2023)
6.4 North America Metabolomics Biomarker Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Metabolomics Biomarker Market Size (2018-2033)
7.2 Europe Metabolomics Biomarker Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Metabolomics Biomarker Market Size by Country (2018-2023)
7.4 Europe Metabolomics Biomarker Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Metabolomics Biomarker Market Size (2018-2033)
8.2 Asia-Pacific Metabolomics Biomarker Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Metabolomics Biomarker Market Size by Region (2018-2023)
8.4 Asia-Pacific Metabolomics Biomarker Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Metabolomics Biomarker Market Size (2018-2033)
9.2 Latin America Metabolomics Biomarker Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Metabolomics Biomarker Market Size by Country (2018-2023)
9.4 Latin America Metabolomics Biomarker Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Metabolomics Biomarker Market Size (2018-2033)
10.2 Middle East & Africa Metabolomics Biomarker Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Metabolomics Biomarker Market Size by Country (2018-2023)
10.4 Middle East & Africa Metabolomics Biomarker Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biocrates Life Sciences
11.1.1 Biocrates Life Sciences Company Detail
11.1.2 Biocrates Life Sciences Business Overview
11.1.3 Biocrates Life Sciences Metabolomics Biomarker Introduction
11.1.4 Biocrates Life Sciences Revenue in Metabolomics Biomarker Business (2018-2023)
11.1.5 Biocrates Life Sciences Recent Development
11.2 Biomark Diagnostics
11.2.1 Biomark Diagnostics Company Detail
11.2.2 Biomark Diagnostics Business Overview
11.2.3 Biomark Diagnostics Metabolomics Biomarker Introduction
11.2.4 Biomark Diagnostics Revenue in Metabolomics Biomarker Business (2018-2023)
11.2.5 Biomark Diagnostics Recent Development
11.3 Chenomx
11.3.1 Chenomx Company Detail
11.3.2 Chenomx Business Overview
11.3.3 Chenomx Metabolomics Biomarker Introduction
11.3.4 Chenomx Revenue in Metabolomics Biomarker Business (2018-2023)
11.3.5 Chenomx Recent Development
11.4 Creative Proteomics
11.4.1 Creative Proteomics Company Detail
11.4.2 Creative Proteomics Business Overview
11.4.3 Creative Proteomics Metabolomics Biomarker Introduction
11.4.4 Creative Proteomics Revenue in Metabolomics Biomarker Business (2018-2023)
11.4.5 Creative Proteomics Recent Development
11.5 Evotec
11.5.1 Evotec Company Detail
11.5.2 Evotec Business Overview
11.5.3 Evotec Metabolomics Biomarker Introduction
11.5.4 Evotec Revenue in Metabolomics Biomarker Business (2018-2023)
11.5.5 Evotec Recent Development
11.6 Human Metabolome Technologies
11.6.1 Human Metabolome Technologies Company Detail
11.6.2 Human Metabolome Technologies Business Overview
11.6.3 Human Metabolome Technologies Metabolomics Biomarker Introduction
11.6.4 Human Metabolome Technologies Revenue in Metabolomics Biomarker Business (2018-2023)
11.6.5 Human Metabolome Technologies Recent Development
11.7 Merck
11.7.1 Merck Company Detail
11.7.2 Merck Business Overview
11.7.3 Merck Metabolomics Biomarker Introduction
11.7.4 Merck Revenue in Metabolomics Biomarker Business (2018-2023)
11.7.5 Merck Recent Development
11.8 Metabolomic Diagnostics
11.8.1 Metabolomic Diagnostics Company Detail
11.8.2 Metabolomic Diagnostics Business Overview
11.8.3 Metabolomic Diagnostics Metabolomics Biomarker Introduction
11.8.4 Metabolomic Diagnostics Revenue in Metabolomics Biomarker Business (2018-2023)
11.8.5 Metabolomic Diagnostics Recent Development
11.9 Metabolon
11.9.1 Metabolon Company Detail
11.9.2 Metabolon Business Overview
11.9.3 Metabolon Metabolomics Biomarker Introduction
11.9.4 Metabolon Revenue in Metabolomics Biomarker Business (2018-2023)
11.9.5 Metabolon Recent Development
11.10 Ovid Therapeutics
11.10.1 Ovid Therapeutics Company Detail
11.10.2 Ovid Therapeutics Business Overview
11.10.3 Ovid Therapeutics Metabolomics Biomarker Introduction
11.10.4 Ovid Therapeutics Revenue in Metabolomics Biomarker Business (2018-2023)
11.10.5 Ovid Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Metabolomics Biomarker Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Protein Marker
Table 3. Key Players of Nucleic Acid Marker
Table 4. Global Metabolomics Biomarker Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Metabolomics Biomarker Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Metabolomics Biomarker Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Metabolomics Biomarker Market Share by Region (2018-2023)
Table 8. Global Metabolomics Biomarker Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Metabolomics Biomarker Market Share by Region (2024-2033)
Table 10. Metabolomics Biomarker Market Trends
Table 11. Metabolomics Biomarker Market Drivers
Table 12. Metabolomics Biomarker Market Challenges
Table 13. Metabolomics Biomarker Market Restraints
Table 14. Global Metabolomics Biomarker Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Metabolomics Biomarker Market Share by Players (2018-2023)
Table 16. Global Top Metabolomics Biomarker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metabolomics Biomarker as of 2022)
Table 17. Ranking of Global Top Metabolomics Biomarker Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Metabolomics Biomarker Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Metabolomics Biomarker Product Solution and Service
Table 21. Date of Enter into Metabolomics Biomarker Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Metabolomics Biomarker Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Metabolomics Biomarker Revenue Market Share by Type (2018-2023)
Table 25. Global Metabolomics Biomarker Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Metabolomics Biomarker Revenue Market Share by Type (2024-2033)
Table 27. Global Metabolomics Biomarker Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Metabolomics Biomarker Revenue Market Share by Application (2018-2023)
Table 29. Global Metabolomics Biomarker Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Metabolomics Biomarker Revenue Market Share by Application (2024-2033)
Table 31. North America Metabolomics Biomarker Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Metabolomics Biomarker Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Metabolomics Biomarker Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Metabolomics Biomarker Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Metabolomics Biomarker Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Metabolomics Biomarker Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Metabolomics Biomarker Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Metabolomics Biomarker Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Metabolomics Biomarker Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Metabolomics Biomarker Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Metabolomics Biomarker Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Metabolomics Biomarker Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Metabolomics Biomarker Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Metabolomics Biomarker Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Metabolomics Biomarker Market Size by Country (2024-2033) & (US$ Million)
Table 46. Biocrates Life Sciences Company Detail
Table 47. Biocrates Life Sciences Business Overview
Table 48. Biocrates Life Sciences Metabolomics Biomarker Product
Table 49. Biocrates Life Sciences Revenue in Metabolomics Biomarker Business (2018-2023) & (US$ Million)
Table 50. Biocrates Life Sciences Recent Development
Table 51. Biomark Diagnostics Company Detail
Table 52. Biomark Diagnostics Business Overview
Table 53. Biomark Diagnostics Metabolomics Biomarker Product
Table 54. Biomark Diagnostics Revenue in Metabolomics Biomarker Business (2018-2023) & (US$ Million)
Table 55. Biomark Diagnostics Recent Development
Table 56. Chenomx Company Detail
Table 57. Chenomx Business Overview
Table 58. Chenomx Metabolomics Biomarker Product
Table 59. Chenomx Revenue in Metabolomics Biomarker Business (2018-2023) & (US$ Million)
Table 60. Chenomx Recent Development
Table 61. Creative Proteomics Company Detail
Table 62. Creative Proteomics Business Overview
Table 63. Creative Proteomics Metabolomics Biomarker Product
Table 64. Creative Proteomics Revenue in Metabolomics Biomarker Business (2018-2023) & (US$ Million)
Table 65. Creative Proteomics Recent Development
Table 66. Evotec Company Detail
Table 67. Evotec Business Overview
Table 68. Evotec Metabolomics Biomarker Product
Table 69. Evotec Revenue in Metabolomics Biomarker Business (2018-2023) & (US$ Million)
Table 70. Evotec Recent Development
Table 71. Human Metabolome Technologies Company Detail
Table 72. Human Metabolome Technologies Business Overview
Table 73. Human Metabolome Technologies Metabolomics Biomarker Product
Table 74. Human Metabolome Technologies Revenue in Metabolomics Biomarker Business (2018-2023) & (US$ Million)
Table 75. Human Metabolome Technologies Recent Development
Table 76. Merck Company Detail
Table 77. Merck Business Overview
Table 78. Merck Metabolomics Biomarker Product
Table 79. Merck Revenue in Metabolomics Biomarker Business (2018-2023) & (US$ Million)
Table 80. Merck Recent Development
Table 81. Metabolomic Diagnostics Company Detail
Table 82. Metabolomic Diagnostics Business Overview
Table 83. Metabolomic Diagnostics Metabolomics Biomarker Product
Table 84. Metabolomic Diagnostics Revenue in Metabolomics Biomarker Business (2018-2023) & (US$ Million)
Table 85. Metabolomic Diagnostics Recent Development
Table 86. Metabolon Company Detail
Table 87. Metabolon Business Overview
Table 88. Metabolon Metabolomics Biomarker Product
Table 89. Metabolon Revenue in Metabolomics Biomarker Business (2018-2023) & (US$ Million)
Table 90. Metabolon Recent Development
Table 91. Ovid Therapeutics Company Detail
Table 92. Ovid Therapeutics Business Overview
Table 93. Ovid Therapeutics Metabolomics Biomarker Product
Table 94. Ovid Therapeutics Revenue in Metabolomics Biomarker Business (2018-2023) & (US$ Million)
Table 95. Ovid Therapeutics Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Metabolomics Biomarker Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Metabolomics Biomarker Market Share by Type: 2022 VS 2033
Figure 3. Protein Marker Features
Figure 4. Nucleic Acid Marker Features
Figure 5. Global Metabolomics Biomarker Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Metabolomics Biomarker Market Share by Application: 2022 VS 2033
Figure 7. Toxicological studies Case Studies
Figure 8. Drug testing Case Studies
Figure 9. Cancer Case Studies
Figure 10. Cardiovascular disorders Case Studies
Figure 11. Neurological disorders Case Studies
Figure 12. Inborn errors of metabolism Case Studies
Figure 13. Metabolomics Biomarker Report Years Considered
Figure 14. Global Metabolomics Biomarker Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global Metabolomics Biomarker Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global Metabolomics Biomarker Market Share by Region: 2022 VS 2033
Figure 17. Global Metabolomics Biomarker Market Share by Players in 2022
Figure 18. Global Top Metabolomics Biomarker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metabolomics Biomarker as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Metabolomics Biomarker Revenue in 2022
Figure 20. North America Metabolomics Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America Metabolomics Biomarker Market Share by Country (2018-2033)
Figure 22. United States Metabolomics Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Metabolomics Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Metabolomics Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Metabolomics Biomarker Market Share by Country (2018-2033)
Figure 26. Germany Metabolomics Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France Metabolomics Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. Metabolomics Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy Metabolomics Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia Metabolomics Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries Metabolomics Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Metabolomics Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Metabolomics Biomarker Market Share by Region (2018-2033)
Figure 34. China Metabolomics Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Japan Metabolomics Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. South Korea Metabolomics Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Southeast Asia Metabolomics Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. India Metabolomics Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Australia Metabolomics Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Metabolomics Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Metabolomics Biomarker Market Share by Country (2018-2033)
Figure 42. Mexico Metabolomics Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Brazil Metabolomics Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Metabolomics Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Metabolomics Biomarker Market Share by Country (2018-2033)
Figure 46. Turkey Metabolomics Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Saudi Arabia Metabolomics Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Biocrates Life Sciences Revenue Growth Rate in Metabolomics Biomarker Business (2018-2023)
Figure 49. Biomark Diagnostics Revenue Growth Rate in Metabolomics Biomarker Business (2018-2023)
Figure 50. Chenomx Revenue Growth Rate in Metabolomics Biomarker Business (2018-2023)
Figure 51. Creative Proteomics Revenue Growth Rate in Metabolomics Biomarker Business (2018-2023)
Figure 52. Evotec Revenue Growth Rate in Metabolomics Biomarker Business (2018-2023)
Figure 53. Human Metabolome Technologies Revenue Growth Rate in Metabolomics Biomarker Business (2018-2023)
Figure 54. Merck Revenue Growth Rate in Metabolomics Biomarker Business (2018-2023)
Figure 55. Metabolomic Diagnostics Revenue Growth Rate in Metabolomics Biomarker Business (2018-2023)
Figure 56. Metabolon Revenue Growth Rate in Metabolomics Biomarker Business (2018-2023)
Figure 57. Ovid Therapeutics Revenue Growth Rate in Metabolomics Biomarker Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed